Assembly Biosciences Inc (ASMB)
17.05
+0.35
(+2.10%)
USD |
NASDAQ |
Nov 14, 16:00
16.79
-0.26
(-1.52%)
After-Hours: 20:00
Assembly Biosciences Free Cash Flow: 24.10M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 24.10M |
| March 31, 2024 | 27.54M |
| December 31, 2023 | 22.49M |
| September 30, 2023 | -70.34M |
| June 30, 2023 | -76.28M |
| March 31, 2023 | -80.49M |
| December 31, 2022 | -84.56M |
| September 30, 2022 | -84.69M |
| June 30, 2022 | -83.65M |
| March 31, 2022 | -87.57M |
| December 31, 2021 | -96.49M |
| September 30, 2021 | -104.13M |
| June 30, 2021 | -74.60M |
| March 31, 2021 | -76.32M |
| December 31, 2020 | -65.18M |
| September 30, 2020 | -58.70M |
| June 30, 2020 | -87.94M |
| March 31, 2020 | -85.48M |
| December 31, 2019 | -85.62M |
| September 30, 2019 | -82.02M |
| June 30, 2019 | -80.14M |
| March 31, 2019 | -75.19M |
| December 31, 2018 | -65.30M |
| September 30, 2018 | -58.49M |
| June 30, 2018 | -53.23M |
| Date | Value |
|---|---|
| March 31, 2018 | -49.49M |
| December 31, 2017 | 0.995M |
| September 30, 2017 | -0.0245M |
| June 30, 2017 | 3.539M |
| March 31, 2017 | 9.128M |
| December 31, 2016 | -35.03M |
| September 30, 2016 | -29.34M |
| June 30, 2016 | -26.63M |
| March 31, 2016 | -24.26M |
| December 31, 2015 | -18.76M |
| September 30, 2015 | -17.01M |
| June 30, 2015 | -15.72M |
| March 31, 2015 | -13.64M |
| December 31, 2014 | -15.12M |
| September 30, 2014 | -16.79M |
| June 30, 2014 | -17.56M |
| March 31, 2014 | -18.62M |
| December 31, 2013 | -17.80M |
| September 30, 2013 | -15.48M |
| June 30, 2013 | -16.11M |
| March 31, 2013 | -19.66M |
| December 31, 2012 | -21.38M |
| September 30, 2012 | -34.64M |
| June 30, 2012 | -33.43M |
| March 31, 2012 | -29.34M |
Free Cash Flow Range, Past 5 Years
-104.13M
Minimum
Sep 2021
27.54M
Maximum
Mar 2024
-64.63M
Average
-80.49M
Median
Mar 2023
Free Cash Flow Benchmarks
| ADMA Biologics Inc | 78.82M |
| Sensus Healthcare Inc | -1.094M |
| Protagonist Therapeutics Inc | 229.23M |
| Precision BioSciences Inc | -48.36M |
| Entrada Therapeutics Inc | -17.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.10M |
| Cash from Investing (Quarterly) | 5.107M |
| Cash from Financing (Quarterly) | 12.45M |
| Free Cash Flow Per Share (Quarterly) | -3.033 |
| Free Cash Flow to Equity (Quarterly) | -17.12M |
| Free Cash Flow to Firm (Quarterly) | -17.12M |
| Free Cash Flow Yield | 27.14% |